|Podcasts|March 3, 2011
Merck's Biosimilars Business, from Parexel's Perspective
Advertisement
Merck's Biosimilars Business, From Parexel's Perspective
Josef von Rickenbach, Chairman and CEO of Parexel, discusses why Parexel won the Merck biosimilars’ business, differences in recruitment for biosimilars, and trends for 2011, including the 20-year promise of technology now being realized.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
If You Build It ... Will They Come?
2
Congressional Funding Deal Boosts Research Space Ahead of Shutdown Deadline
3
FDA RWE Guidance Redefines Data Use in Clinical Operations
4
The Evolution of Global Trial Strategies in Today's Complex Healthcare Landscape
5